|
08:30-10:30 |
HEADACHE, SLEEP AND THE MIND |
|
Chairs: Raquel Gil-Gouveia, Portugal; Krystyna Mitosek-Szewczyk, Poland |
08:30-09:30 |
Proposition: Behavioral therapy is necessary for the complete treatment of migraine |
|
Capsule: Medication and psychological intervention are often used in primary headache disorders. Are both necessary? |
08:30-08:40 |
Host: Robert Shapiro, USA |
08:40-08:55 |
Yes: Randall Weeks, USA |
08:55-09:10 |
No: Frank Andrasik, USA |
09:10-09:30 |
Discussion and rebuttals |
|
09:30-10:30 |
Proposition: Optimal sleep therapy is superior to migraine preventive medications |
|
Capsule: Patients who do not sleep well develop headaches or have more severe headaches. Would optimal sleep therapies ever be good enough to take the place of medication for treatment of migraine? |
09:30-09:40 |
Host: Jack Schim, USA |
09:40-09:55 |
Yes: Hans Hamburger, The Netherlands |
09:55-10:10 |
No: Robert Shapiro, USA |
10:10-10:30 |
Discussion and rebuttals |
|
10:45-12:45 |
HEADACHE TRIALS AND THE USE OF TECHNOLOGY TO TRACK AND DIAGNOSE |
|
Chair: Elsa Paixao Parreira, Portugal; Magda Wysocka-Bakowska, Poland |
10:45-11:45 |
Proposition: Computers can accurately diagnose primary headache disorders as well as most physicians |
|
Capsule: Personalized medicine (patient and doctor in the same room) is rapidly being replaced by modern e-techniques and information technology tools |
10:45-10:55 |
Host: Jose Pereira Monteiro, Portugal |
10:55-11:10 |
Yes: Robert Cowan, USA |
11:10-11:25 |
|
11:25-11:45 |
Discussion and rebuttals |
|
11:45-12:45 |
Debate: The use of placebo is essential in headache trials |
|
Capsule: The use of placebo as a control in headache trials has been questioned when efficacious treatments are available. How important is the placebo? |
11:45-11:55 |
Host: Frank Andrasik, USA |
11:55-12:10 |
Yes: Randall Weeks, USA |
12:10-12:25 |
No: Dimos Mitsikostas, Greece |
12:25-12:45 |
Discussion and rebuttals |
|
15:00-17:00 |
TREATMENT OF CHRONIC HEADACHE |
|
Chairs: Min Kyung Chu, South Korea; Isabel Pavão Martins, Portugal |
15:00-15:20 |
Lecture: The history of CGRP discovery and its importance today |
|
Lars Edvinsson, Sweden |
|
15:20-16:10 |
Debate: CGRP antibodies will become the treatment of choice for chronic migraine |
|
Capsule: CGRP plays a crucial role in migraine pathophysiology. CGRP antagonists are efficacious but have not done well in clinical development. Monoclonal antibodies to CGRP or its receptor are promising new molecules for preventive treatment in migraine. Will they come to be the treatment of choice? |
15:20-15:30 |
Host: Alan Rapoport, USA |
15:30-15:45 |
Yes: Lars Edvinsson, Sweden |
15:45-16:00 |
No: Jose Miguel Lainez, Spain |
16:00-16:10 |
Discussion and rebuttals |
|
16:10-17:00 |
Proposition: Medication over-use is the main causative factor in chronic migraine |
|
Capsule: Stimulation procedures have been developed recently to treat refractory migraine and cluster headache. The clinical value of these procedures is still being investigated |
16:10-16:20 |
Host: Alan Rapoport, USA |
16:20-16:35 |
Yes: Jose Miguel Lainez, Spain |
16:36-16:50 |
No: Hayrunnisa Bolay, Turkey |
16:50-17:00 |
Discussion and rebuttals |
|
17:15-19:00 |
CORTICAL SPREADING DEPRESSION; CLUSTER HEADACHE |
|
Chairs: Vladimir Romanenko, Ukraine: Oved Daniel, Israel |
17:15-18:10 |
Proposition: Migraine starts in the cortex |
|
Capsule: Cortical spreading depression is prevalent in the migraine brain, but is this what triggers the migraine attack? |
17:15-17:25 |
Host: Robert Cowan, USA |
17:25-17:40 |
Yes: Hayrunnisa Bolay, Turkey |
17:40-17:55 |
No: Lars Edvinsson, Sweden |
17:55-18:10 |
Disussion and rebuttals |
|
18:10-19:00 |
Debate: Electrical stimulation will replace medications for the treatment of cluster headache |
|
Capsule: Many forms of electrical stimulation have been studied for migraine and cluster. Two of them have targeted cluster headache. Are they good enough to rival medication? |
18:10-18:20 |
Host: Hans Hamburger, The Netherlands |
18:20-18:35 |
Yes: Stephen Silberstein, USA |
18:35-18:50 |
No: Jose Pereira Monteiro, Portugal |
18:50-19:00 |
Discussion and rebuttals |